UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 75

Sortiert nach

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

Journal of investigative dermatology, 2015-07, Vol.135 (7), p.1820-1828

2015

Volltextzugriff (PDF)

Assessing Novel Therapies Based on Late-Stage Efficacy: A Dangerous Concept?

Trends in cancer, 2021-03, Vol.7 (3), p.181-185

Lønning, Per E

2021

Volltextzugriff (PDF)

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

Cancer & metabolism, 2019-06, Vol.7 (1), p.6-6, Article 6

2019

Volltextzugriff (PDF)

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions

Therapeutic Advances in Medical Oncology, 2012-05, Vol.4 (3), p.127-137

Lønning, Per E.

2012

Volltextzugriff (PDF)

Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk

Transcription, 2011-09, Vol.2 (5), p.207-210

2011

Volltextzugriff (PDF)

Comment on "Towards a personalized approach to aromatase inhibitor therapy: a digital microfluidic platform for rapid analysis of estradiol in core-needle-biopsies" by S. Abdulwahab, A. H. C. Ng, M. D. Chamberlain, H. Ahmado, L.-A. Behan, H. Gomaa, R. F. Casper and A. R. Wheeler, Lab Chip, 2017, 17, 1594

Lab on a chip, 2017-09, Vol.17 (18), p.3186-3187

Lønning, Per E

2017

Volltextzugriff (PDF)

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

Translational oncology, 2017-10, Vol.10 (5), p.806-817

2017

Volltextzugriff (PDF)

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Journal of investigative dermatology, 2010-10, Vol.130 (10), p.2514-2516

2010

Volltextzugriff (PDF)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Genome medicine, 2022-08, Vol.14 (1), p.1-86, Article 86

2022

Volltextzugriff (PDF)

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

Gene, 2021-08, Vol.793, p.145747-145747, Article 145747

2021

Volltextzugriff (PDF)

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Cell Stress, 2019-03, Vol.3 (4), p.118-135

2019

Volltextzugriff (PDF)

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters

Molecular cancer, 2006-10, Vol.5 (1), p.47-47

2006

Volltextzugriff (PDF)

Assessment of tumor suppressor promoter methylation in healthy individuals

Clinical epigenetics, 2020-08, Vol.12 (1), p.131-131, Article 131

2020

Volltextzugriff (PDF)

Aromatase inhibitors—Socioeconomical issues

Journal of steroid biochemistry and molecular biology, 2007-08, Vol.106 (1), p.55-61

2007

Volltextzugriff (PDF)

Microarray Analysis Reveals a Major Direct Role of DNA Copy Number Alteration in the Transcriptional Program of Human Breast Tumors

Proceedings of the National Academy of Sciences - PNAS, 2002-10, Vol.99 (20), p.12963-12968

2002

Volltextzugriff (PDF)

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

JCO precision oncology, 2023-09, Vol.7, p.e2300338

2023

Volltextzugriff (PDF)

Clinical pharmacokinetics of aromatase inhibitors and inactivators

Clinical pharmacokinetics, 2003-01, Vol.42 (7), p.619-631

Lonning, Per E

2003

Volltextzugriff (PDF)

The multitude of molecular analyses in cancer: the opening of Pandora’s box

Genome Biology, 2014-09, Vol.15 (9), p.447-447, Article 447

2014

Volltextzugriff (PDF)

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

Scientific reports, 2016-09, Vol.6 (1), p.33153, Article 33153

2016

Volltextzugriff (PDF)

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Nature medicine, 1996-07, Vol.2 (7), p.811-814

1996

Volltextzugriff (PDF)

Prevalence of the CHEK2 R95 germline mutation

Hereditary cancer in clinical practice, 2016-09, Vol.14 (1), p.19-19, Article 19

2016

Volltextzugriff (PDF)

Genomsekvensering for persontilpasset kreftbehandling

Tidsskrift for den Norske Lægeforening, 2012, Vol.132 (21), p.2406-2408

2012

Volltextzugriff (PDF)

Aromatase inhibitors—Socio-economical issues

Journal of steroid biochemistry and molecular biology, 2005-05, Vol.95 (1), p.137-142

2005

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(67)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

Assessing Novel Therapies Based on Late-Stage Efficacy: A Dangerous Concept?

Epithelial to mesenchymal transition (EMT) is associated with attenuation of succinate dehydrogenase (SDH) in breast cancer through reduced expression of SDHC

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions

Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Expression of full-length p53 and its isoform Δp53 in breast carcinomas in relation to mutation status and clinical parameters

Assessment of tumor suppressor promoter methylation in healthy individuals

Aromatase inhibitors—Socioeconomical issues

Microarray Analysis Reveals a Major Direct Role of DNA Copy Number Alteration in the Transcriptional Program of Human Breast Tumors

Homologous Recombination Deficiency Across Subtypes of Primary Breast Cancer

Clinical pharmacokinetics of aromatase inhibitors and inactivators

The multitude of molecular analyses in cancer: the opening of Pandora’s box

MDM2 promoter SNP55 (rs2870820) affects risk of colon cancer but not breast-, lung-, or prostate cancer

Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients

Population distribution and ancestry of the cancer protective MDM2 SNP285 (rs117039649)

Prevalence of the CHEK2 R95 germline mutation

Genomsekvensering for persontilpasset kreftbehandling

Aromatase inhibitors—Socio-economical issues

Aktive Filter

Suchergebnisse filtern